TXG
10x Genomics, Inc.
Nasdaq Laboratory Analytical Instruments Large accelerated filer

Key Financials

Net Income
$-43544000
↑ 76.2%
Gross Profit
$443.9M
↑ 7.1%
Total Assets
$1.0B
↑ 13.4%
Total Liabilities
$245.0M
↑ 17.5%
Operating Income
$-60985000
↑ 68.7%
Shareholders' Equity
$796.3M
↑ 12.1%
EPS (Diluted)
$-0.35
↑ 77.0%
Revenue
$642.8M
↑ 5.2%

Recent SEC Filings

Form Type Filed Date Link
10-Q 5/8/2026 View on SEC
8-K 5/7/2026 View on SEC
SCHEDULE 13G 4/29/2026 View on SEC
SCHEDULE 13G 4/28/2026 View on SEC
DEFA14A 4/24/2026 View on SEC
DEF 14A 4/24/2026 View on SEC
4 4/16/2026 View on SEC
4 3/25/2026 View on SEC
SCHEDULE 13G/A 3/25/2026 View on SEC
SCHEDULE 13G/A 3/24/2026 View on SEC

Company Information

Field Value
Ticker TXG
Company Name 10x Genomics, Inc.
CIK 1770787
Sector Laboratory Analytical Instruments
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 3826
SIC Description Laboratory Analytical Instruments
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (925) 401-7300